Ionis Pharmaceuticals, Inc. (IONS)
IONS price $44.27 -1.13 -2.49%
- Ticker
- IONS
- Price
- $44.27
- Change
- -1.13 -2.49%
- Market cap
- $7.36B
- P/E
- -12.79
- Forward P/E
- 214.53
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 48
Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy…